Treatment Challenges in Venous Thromboembolism: An Appraisal of Rivaroxaban Studies
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Treatment Challenges in Venous Thromboembolism: An Appraisal of Rivaroxaban Studies ; volume:118 ; number:S 01 ; year:2018 ; pages:S23-S33 ; 01
Thrombosis and haemostasis ; 118, Heft S 01 (2018), S23-S33, 01
- Contributor
-
Khorana, Alok A.
Weitz, Jeffrey I.
- DOI
-
10.1160/TH17-09-0681
- URN
-
urn:nbn:de:101:1-2018122910432212120574
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:00 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Khorana, Alok A.
- Weitz, Jeffrey I.
Other Objects (12)
Cancer‐associated venous thromboembolism: Treatment and prevention with rivaroxaban
Rivaroxaban treatment for asymptomatic venous thromboembolism: insights from the J’xactly study
Postthrombotic Syndrome in Patients Treated With Rivaroxaban or Warfarin for Venous Thromboembolism
Comparison of rivaroxaban and parnaparin for preventing venous thromboembolism after lumbar spine surgery
Venous anomalies and thromboembolism
Oral rivaroxaban for Japanese patients with symptomatic venous thromboembolism – the J-EINSTEIN DVT and PE program
Clot-regression effects of rivaroxaban in venous thromboembolism treatment in cancer patients—a prospective interventional study
Rivaroxaban versus Apixaban for Treatment of Cancer-Associated Venous Thromboembolism in Patients at Lower Risk of Bleeding
Pooled Analysis of Rivaroxaban therapy for acute venous thromboembolism in FIRST registry, SWIVTER and DRESDEN NOAC registry
Proteomic analysis of extracellular vesicle cargoes mirror the cardioprotective effects of rivaroxaban in patients with venous thromboembolism
Circumstances of provoked recurrent venous thromboembolism: the Austrian study on recurrent venous thromboembolism
Venous thromboembolism : prevention and treatment
Cancer‐associated venous thromboembolism: Treatment and prevention with rivaroxaban
Rivaroxaban treatment for asymptomatic venous thromboembolism: insights from the J’xactly study
Postthrombotic Syndrome in Patients Treated With Rivaroxaban or Warfarin for Venous Thromboembolism
Comparison of rivaroxaban and parnaparin for preventing venous thromboembolism after lumbar spine surgery
Venous anomalies and thromboembolism
Oral rivaroxaban for Japanese patients with symptomatic venous thromboembolism – the J-EINSTEIN DVT and PE program
Clot-regression effects of rivaroxaban in venous thromboembolism treatment in cancer patients—a prospective interventional study
Rivaroxaban versus Apixaban for Treatment of Cancer-Associated Venous Thromboembolism in Patients at Lower Risk of Bleeding
Pooled Analysis of Rivaroxaban therapy for acute venous thromboembolism in FIRST registry, SWIVTER and DRESDEN NOAC registry
Proteomic analysis of extracellular vesicle cargoes mirror the cardioprotective effects of rivaroxaban in patients with venous thromboembolism
Circumstances of provoked recurrent venous thromboembolism: the Austrian study on recurrent venous thromboembolism
Venous thromboembolism : prevention and treatment
Cancer‐associated venous thromboembolism: Treatment and prevention with rivaroxaban
Rivaroxaban treatment for asymptomatic venous thromboembolism: insights from the J’xactly study
Postthrombotic Syndrome in Patients Treated With Rivaroxaban or Warfarin for Venous Thromboembolism
Comparison of rivaroxaban and parnaparin for preventing venous thromboembolism after lumbar spine surgery
Venous anomalies and thromboembolism
Oral rivaroxaban for Japanese patients with symptomatic venous thromboembolism – the J-EINSTEIN DVT and PE program
Clot-regression effects of rivaroxaban in venous thromboembolism treatment in cancer patients—a prospective interventional study
Rivaroxaban versus Apixaban for Treatment of Cancer-Associated Venous Thromboembolism in Patients at Lower Risk of Bleeding
Pooled Analysis of Rivaroxaban therapy for acute venous thromboembolism in FIRST registry, SWIVTER and DRESDEN NOAC registry
Proteomic analysis of extracellular vesicle cargoes mirror the cardioprotective effects of rivaroxaban in patients with venous thromboembolism
Circumstances of provoked recurrent venous thromboembolism: the Austrian study on recurrent venous thromboembolism